Literature DB >> 11327283

Glucocorticoids but not NSAID abort attacks in hyper-IgD and periodic fever syndrome.

J de Dios García-Díaz, M J Alvarez-Blanco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11327283

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  7 in total

1.  Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.

Authors:  Donato Rigante; Valentina Ansuini; Barbara Bertoni; Anna Lisa Pugliese; Laura Avallone; Gilda Federico; Achille Stabile
Journal:  Rheumatol Int       Date:  2006-07-27       Impact factor: 2.631

2.  Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome.

Authors:  Hiba M Shendi; Deirdre Walsh; J David M Edgar
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 2.631

3.  Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up.

Authors:  Rezan Topaloğlu; Nuray Aktay Ayaz; Hans R Waterham; Aysel Yüce; Fatma Gumruk; Ozden Sanal
Journal:  Clin Rheumatol       Date:  2008-05-28       Impact factor: 2.980

4.  [Genetic fever syndromes. Hereditary recurrent (periodic) fever syndromes].

Authors:  U Neudorf; E Lainka; T Kallinich; D Holzinger; J Roth; D Föll; T Niehues
Journal:  Z Rheumatol       Date:  2013-05       Impact factor: 1.372

5.  A Case of Hyper IgD and Periodic Fever Syndrome in Japan.

Authors:  Hisashi Kawashima; Akiyoshi Hoshi; Hiroaki Ioi; Chiako Ishii; Satoshi Sato; Yasuyo Kashiwagi; Kouji Takekuma; Akinori Hoshika
Journal:  Clin Med Case Rep       Date:  2008-05-16

6.  Periodic Fever: A Review on Clinical, Management and Guideline for Iranian Patients - Part II.

Authors:  Zahra Ahmadinejad; Sedigeh Mansouri; Vahid Ziaee; Yahya Aghighi; Mohammad-Hassan Moradinejad; Fatemeh Fereshteh-Mehregan
Journal:  Iran J Pediatr       Date:  2014-06       Impact factor: 0.364

7.  B cell cytopenia in two brothers with hyper-IgD and periodic fever syndrome.

Authors:  M Sornsakrin; K Wenner; R Ganschow
Journal:  Eur J Pediatr       Date:  2008-10-07       Impact factor: 3.860
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.